Metabolomics Creative Proteomics
Submit Your Inquiry

Quantitative Glycan Metabolism & Pathway Flux Analysis

Go beyond static glycan profiles. Creative Proteomics provides high-sensitivity, targeted LC-MS/MS to quantify the metabolic pathways that power glycosylation. We deliver precise, absolute quantification of critical precursors, intermediates, and cofactors across the hexosamine biosynthesis pathway (HBP), sialic acid synthesis, and fucosylation—so you can interpret not just what glycan structures look like, but why they change.

For dynamic insight, our platform supports stable isotope tracing to measure pathway activity and metabolic flux, not just steady-state concentrations.

Key advantages

  • Broad pathway coverage: HBP, sialic acid, fucose, and GAG/GSL precursor pathways.
  • Absolute quantification: Isotope-labeled internal standards; results reported in μM or nmol/mg protein.
  • Flux-ready analytics: Fully compatible with ^13C and ^15N tracers for quantitative pathway flux analysis.
  • High sensitivity: nM-level LLOQs suitable for limited material (cell lysates, micro-tissues, biofluids).
CONTACT EXPERT
  • Service Details
  • FAQ
  • Publications
  • Submit Your Inquiry

Why Measure Glycan Metabolism?

Glycosylation is tightly regulated by metabolic input—not just enzyme activity. Key pathways like the Hexosamine Biosynthesis Pathway (HBP) integrate glucose, glutamine, acetyl-CoA, and UTP to produce UDP-GlcNAc, the essential donor for O-GlcNAcylation and N-glycan branching. Elevated HBP activity is a hallmark of metabolic reprogramming in cancer and immune activation.

Likewise, levels of CMP-Sialic Acid directly control the cell's capacity for sialylation, a key modification in immune evasion and metastasis. These and other nucleotide sugars function as metabolic checkpoints that link nutrient availability to glycan output.

Quantifying these intermediates provides a sensitive, upstream, and mechanistic view of glycosylation changes, often revealing biological shifts earlier than structural glycan profiling.

What We Quantify: High-Coverage, Targeted Panels for Glycan Metabolism

Creative Proteomics offers curated, LC-MS/MS–based panels targeting key metabolites across glycan biosynthesis and nucleotide sugar metabolism. These panels are designed to quantify metabolic inputs relevant to N- and O-glycosylation, sialylation, fucosylation, and glycosaminoglycan (GAG) biosynthesis.

Our platform targets nucleotide sugars, pathway intermediates, and metabolic cofactors—ensuring decision-ready data for mechanistic studies, disease models, and drug development.

Representative Metabolites in Glycan Biosynthesis Pathways

Pathway Representative Metabolites
Hexosamine Biosynthesis & Core Precursors Glucose-6-phosphate, Fructose-6-phosphate, Glucosamine-6-phosphate, GlcNAc-6-phosphate, GlcNAc-1-phosphate, UDP-GlcNAc, UDP-GalNAc, UDP-Glucose, UDP-Galactose
Sialic Acid Pathway ManNAc, ManNAc-6-phosphate, Neu5Ac (Sialic Acid), CMP-Neu5Ac (CMP-Sialic Acid)
Fucosylation Pathway GDP-Mannose, GDP-Fucose
GAG / GSL Precursors UDP-Glucuronic Acid (UDP-GlcA), UDP-Xylose; upstream indicators for Glycosaminoglycan Biosynthesis (including Chondroitin Sulfate / Dermatan Sulfate, Heparan Sulfate / Heparin, Keratan Sulfate) and Glycosphingolipid Biosynthesis (including Lacto and Neolacto Series, Globo and Isoglobo Series, Ganglio Series).
Nucleotide Cofactors ATP, UTP, CTP, GTP, Acetyl-CoA

Custom panels are available. Please inquire if your project requires specific pathway branches or rare intermediates.

Pathway Flux Analysis: Measuring Metabolic Activity Through Isotope Tracing

To investigate not just metabolite abundance but how actively pathways are functioning, we support Stable Isotope Tracing (SIT) using 13C- or 15N-labeled substrates. This approach enables quantitative analysis of flux through glycan-related pathways by tracking label incorporation into downstream metabolites.

By analyzing the isotopic distribution of compounds such as UDP-GlcNAc, CMP-Neu5Ac, or other nucleotide sugars, researchers can assess de novo synthesis rates, substrate utilization, and pathway dynamics under different biological or experimental conditions.

What the Service Includes

  • Experimental Setup Support
    We assist in tracer selection, labeling duration, and sampling timing based on the turnover characteristics of your target pathway.
  • Isotopologue Analysis via High-Resolution LC-MS/MS
    Orbitrap instrumentation allows precise quantification of labeled isotopologues across multiple metabolic intermediates.
  • Data Interpretation and Reporting
    Results include isotopologue distributions, labeling patterns, and fractional enrichment, which can be used to infer relative pathway activity or response to perturbation.

Why Choose Our Glycan Metabolism & Pathway Flux Analysis?

  • Ultra-sensitive quantification — Detect nucleotide sugars and intermediates down to 0.5–10 nM.
  • High linearity and recovery — Calibration R² ≥ 0.995, recovery 85–115%, ensuring true absolute values.
  • Dual-instrument precision — Agilent 6495C QQQ for quantitation + Orbitrap HF-X for isotopologue flux analysis.
  • Reproducible performance — Inter- and intra-batch CV ≤ 15% for confident multi-sample comparison.
  • Flux-ready analytics — Quantify ¹³C/¹⁵N label incorporation to reveal real-time pathway activity.
  • Matrix-validated methods — Optimized extraction and calibration for cells, tissues, and biofluids.
  • Integrated interpretation — Deliverables include isotopologue distribution + KEGG-mapped pathway insights.
  • Actionable biological insight— Translate metabolic data into clear evidence of glycosylation regulation.

Technology & Validation for Glycan Metabolite Quantification

Our glycan metabolism and flux analysis services are built on validated LC-MS/MS platforms with stringent quality control procedures. We apply a dual-instrument strategy optimized for both absolute quantification and isotopologue resolution:

  • Agilent 6495C Triple Quadrupole (QQQ) in dynamic MRM mode is used for targeted quantification, offering excellent sensitivity and linearity across wide dynamic ranges.
  • Thermo Q Exactive™ HF-X Hybrid Orbitrap is employed for high-resolution isotopologue detection and discovery-based analysis in flux studies.
  • Specialized Chromatography: HILIC (amide-based) and Porous Graphitic Carbon (PGC) methods are selected based on analyte polarity and structural similarity, particularly for isomeric nucleotide sugars.

Method Performance and Quality Specifications

Parameter Specification Notes
Sensitivity LLOQ as low as 0.5–10 nM (matrix-dependent) Enables measurement from low-input samples (e.g., primary cells, micro-dissected tissues)
Precision %RSD ≤ 15% (intra- and inter-batch) Supports reproducibility across large cohorts
Linearity R² ≥ 0.995 across 3–4 orders of magnitude Maintains accuracy from trace to abundant metabolites
Accuracy QC recovery within 85–115% Ensures reliability of reported concentrations
Agilent 6495C Triple Quadrupole

Agilent 6495C Triple Quadrupole (Figure from Agilent)

Agilent 1260 Infinity II HPLC

Agilent 1260 Infinity II HPLC (Fig from Agilent)

Workflow for Quantitative Glycan Metabolism Analysis

1

Project Scoping — Define objectives, target pathways/analytes, matrices, and (if applicable) isotope tracing strategy.

2

Method Fit & Panel Finalization — Confirm analyte list, internal standards, calibration range, and acceptance criteria.

3

Sample Preparation & Shipment — Follow metabolomics SOPs; freeze promptly and ship on dry ice to maintain integrity.

4

Extraction & Batch QC — Cold-chain extraction with process blanks, matrix QCs, and calibration standards in each batch.

5

Targeted LC-MS/MS Acquisition — dMRM/PRM acquisition with isotope-labeled internal standards; routine system suitability checks.

6

Reporting & Review — Deliver quantitative tables, QC metrics, and (if applicable) isotopologue data for flux interpretation; optional consult for data review.

Workflow for quantitative glycan metabolism analysis

Sample Requirements for Glycan Metabolism LC-MS/MS Analysis

Sample Type Collection & Quench (Timing) Pre-Analytical Handling Minimum Amount Storage & Shipping
Cell Pellets Quench immediately (≤ 30 s) 80% cold methanol quench or cold PBS wash → liquid-N₂ snap-freeze ≥ 1×10⁶ cells Store –80 °C; ship on dry ice
Tissues Excise and snap-freeze < 10 s post-harvest Avoid thawing; trim excess blood; aliquot if large ≥ 20 mg Store –80 °C; ship on dry ice
Plasma / Serum Separate from whole blood < 30 min Avoid hemolysis; aliquot to prevent repeat freeze–thaw ≥ 100 µL Store –80 °C; ship on dry ice
Cell Culture Media Collect and clarify immediately Spin at 4 °C to remove debris; snap-freeze supernatant ≥ 200 µL Store –80 °C; ship on dry ice

Notes: Use low-bind tubes; keep materials pre-chilled; record time-to-quench; label with Project/Sample ID & date; provide normalization data (preferred: protein by BCA; alternatives: cell count or tissue weight). For SIT, include tracer type, enrichment, and labeling duration.

What You Receive: Deliverables from Our Glycan Metabolism Analysis

  • Quantitative concentration table: All analytes, sample IDs, final units (μM or nmol/mg protein).
  • Full QC report: L/M/H QCs, calibration (R²), %RSD, accuracy, retention time windows, and acceptance criteria.
  • Flux analysis report (if applicable): Isotopologue distributions, fractional enrichment, and pathway-specific flux visuals.
  • Methodology summary: A "Materials & Methods" section ready for manuscripts and regulatory documentation.
  • Raw data on request: .raw or .mzML files for archival and independent review.
Overlaid EICs of analyte and isotope internal standard co-eluting at ~2.0 min with a low matrix-blank trace.

Co-elution & Selectivity (Single EIC Overlay)

High-resolution MS/MS spectrum with labeled fragment m/z peaks and ppm error for the target analyte.

High-Resolution Product-Ion Spectrum (Single MS/MS Spectrum)

Research Applications of Glycan Metabolism Quantification

Cancer Cell Biology

Quantify nucleotide-sugar pools to map glycosylation-relevant metabolic rewiring.

Immunometabolism

Track precursor availability during immune cell activation and phenotype transitions.

Neuroscience Research

Assess UDP-GlcNAc dynamics to study O-GlcNAc–linked neuronal regulation.

Stem Cell & Differentiation

Monitor pathway precursors across lineage commitment and maturation.

Bioprocess & Cell Culture Optimization

Profile media-dependent impacts on glycan-related metabolism in vitro.

Enzymology & Chemical Biology 

Evaluate pathway perturbations to probe glycosylation enzyme mechanisms.

What is the hexosamine biosynthesis pathway (HBP) and why does it matter for glycan metabolism?

The HBP integrates glucose, glutamine, acetyl-CoA, and UTP to generate UDP-GlcNAc—a central nutrient sensor that links cellular metabolism to glycosylation capacity and signaling via O-GlcNAc; shifts in HBP flux often precede detectable changes in glycan structures.

Which nucleotide sugars are most informative when assessing glycosylation capacity?

UDP-GlcNAc (HBP), CMP-Neu5Ac (sialylation), and GDP-Fucose (fucosylation) act as proximal "supply checkpoints" for major glycan modifications, so their pool sizes and labeling patterns are strong readouts of pathway readiness.

How does CMP-sialic acid relate to immune evasion in cancer?

Elevated sialylation increases "self-associated" signals and can mask antigens or engage inhibitory Siglec receptors, dampening antitumor immunity—so CMP-Neu5Ac supply and sialylation flux are mechanistically relevant to immune escape.

What's the difference between de novo and salvage GDP-fucose, and why should I care?

Cells produce GDP-fucose via a de novo route from GDP-mannose and a salvage route from free fucose; their contributions can rebalance under genetic or metabolic constraints, so resolving source-specific flux helps explain fucosylation changes.

When is flux analysis more useful than steady-state metabolite profiling?

Flux with stable isotope tracing reveals pathway activity (rates and routing) that pool sizes can't capture, clarifying whether observed concentration shifts reflect altered synthesis, consumption, or rerouting under perturbation.

Which tracers are commonly used to study glycan-related pathways?

13C and 15N substrates are standard for quantifying routing into nucleotide sugars (for example, label flow into UDP-GlcNAc or CMP-Neu5Ac), enabling direct measurement of de novo synthesis and pathway engagement.

How do you separate isomeric or closely related nucleotide sugars for LC–MS/MS?

Methods employ HILIC, porous graphitic carbon, or mixed-mode anion-exchange/RP to resolve isomeric nucleotide sugars with validated linearity and reproducibility—critical for confident quantification.

Can glycan-metabolism measurements explain why structural glycomics changes occur?

Yes—nucleotide sugar supply and upstream pathway flux often drive or constrain downstream glycosylation outcomes, offering a mechanistic rationale for structural shifts observed in glycomics or glycoproteomics datasets.

Does O-GlcNAc reflect cellular nutrient status relevant to pathway interpretation?

O-GlcNAc is dynamically regulated by UDP-GlcNAc and coordinates with metabolic and circadian programs, so changes in HBP flux can propagate into signaling and timing phenotypes that contextualize glycan metabolism data.

Can flux analysis help with target validation or MoA studies in oncology or immunology?

By resolving how carbon or nitrogen flows into nucleotide sugars that control sialylation, fucosylation, or O-GlcNAc, isotope tracing links metabolic interventions to functional glycosylation outputs, strengthening mechanism-of-action claims.

What matrices are appropriate if I want pathway-level insight instead of only end-product glycans?

Cell lysates, tissues, and biofluids can all inform pathway state, but intracellular nucleotide sugars and labeled isotopologues from cells or tissues usually provide the most direct view of synthesis and routing into glycosylation.

How do these measurements complement glycoproteomics?

Glycoproteomics reports site-specific structure and occupancy, while metabolite and flux assays report precursor supply and pathway drive; together they connect "what changed" in glycans with "why it changed" metabolically.

UDP-Glucose/P2Y14 Receptor Signaling Exacerbates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats

Kanamaru, H., Zhu, S., Dong, S., Takemoto, Y., Huang, L., Sherchan, P., … & Zhang, J. H.

Stroke

Year: 2024

Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells

Kerselidou, D., Dohai, B. S., Nelson, D. R., Daakour, S., De Cock, N., Hassoun, Z. A. O., … & Twizere, J. C.

Science Advances

Year: 2021

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201

Tsang, K. Y., Fantini, M., Zaki, A., Mavroukakis, S. A., Morelli, M. P., Annunziata, C. M., & Arlen, P. M.

Cancers

Year: 2022

Modulation of the Endomembrane System by the Anticancer Natural Product Superstolide/ZJ-101

Sanchez, P. R., Head, S. A., Qian, S., Qiu, H., Roy, A., Jin, Z., … & Liu, J. O.

International Journal of Molecular Sciences

Year: 2023

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion

Xia, T., Wu, X., Hong, E., Jung, K., Lai, C. J., Kwak, M. J., … & Jung, J. U.

PLOS Pathogens

Year: 2023

Effects of microbial phytase on mucin synthesis, gastric protein hydrolysis, and degradation of phytate along the gastrointestinal tract of growing pigs

Mesina, V. G., Lagos, L. V., Sulabo, R. C., Walk, C. L., & Stein, H. H.

Journal of Animal Science

Year: 2019

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top